Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Target-Controlled Infusion (TCI) on Neurocognitive Functions in Postoperative Sedoanalgesia Management in Geriatric Patients Undergoing Major Surgery

NCT07311447 is registered in ClinicalTrials.gov with Namigar Turgut as lead sponsor.

NCT NCT07311447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07311447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Target-Controlled Infusion (TCI) on Neurocognitive Functions in Postoperative Sedoanalgesia Management in Geriatric Patients Undergoing Major Surgery
Lead sponsor
Namigar Turgut
Phase
Observational
Overall status
Completed
Start date
May 5, 2025
Completion date
October 31, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

geriatric patients, neurocognitive function, postoperative cognitive dysfunction (pocd), sedation and analgesia